Time Finance Regulatory News (TIME)

28 Oct 2009 07:00

28th October 2009 

TIME.L 

Timestrip plc 

("Timestrip" or "the Company")) 

Timestrip I.V. - First full adoption by NHS Trust 

Timestrip plc is delighted to announce that Walton Centre NHS Foundation Trust will become the first NHS Trust to fully adopt Timestrip I.V. into its protocol for monitoring the dwell-time of Peripheral Intravenous Cannulae (PVC's). Vygon (UK) Ltd., the Main Distributor in the UK and Ireland for Timestrip I.V., has secured the contract to supply cannulation packs to Walton Centre NHS Foundation Trust. The unique and patented TimestripIV product will be included as a standard component in every pack. 

Timestrip I.V. is an innovative technology that enables clinicians and patients to quickly assess how long a cannula has been in place and thus take appropriate action in line with hospital infection control procedures. Up to 60% of cases of blood infections known as MRSA Bacteraemia are caused by PVC's and the cost of treating MRSA is estimated at £1 billion per annum, according to the National Audit Office. Launched in July 2009, Timestrip I.V. is currently being used and trialled by more than 25 other NHS hospitals. 

Paul Freedman, Joint CEO, TimestripPlc: "The first full conversion of a NHS Trust is a major milestone for the business and has been achieved by the team at Vygon (UK) Ltd. in a relatively short period of time. Timestrip I.V. is now gaining excellent exposure within the NHS and we are optimistic that more Trust conversions are achievable in the future. I am also very encouraged by the number of international enquiries for Timestrip I.V. that we have received in recent weeks, including several from North America. 

Ends 

For more information please contact: 

Paul Freedman, Joint CEO, Timestrip Plc 01462 440700 

Geoff Nash, FinnCap, NOMAD 020 7600 1658